FOLFIRINOX
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
FOLFIRINOX
Apr 12, 2024, 14:08 |
Insight
Erman Akkus: Pancreatic cancer clinical trials in AACR24
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Pancreatic cancer clinical trials…
Mar 27, 2024, 13:02 |
Blog
Erman Akkus: ESMO-2023, hepatobiliary and pancreatic cancers
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "ESMO-2023, hepatobiliary and pancreatic…
Feb 10, 2024, 15:18 |
Drugs
Erman Akkus: Localized pancreatic adenocancer treated with initial neoadjuvant FOLFIRINOX
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Localized pancreatic adenocancer treated with…
Oct 23, 2023, 13:15 |
Drugs
Pashtoon Kasi: We should drop the modified nomenclature and just agree on just dosing schema for FOLFIRINOX
Quoting Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine, on X/Twitter: ''ESMO23 Moving forward…
All:
4
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube